Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Abiomed (ABMD) Q4 2020 earnings report
Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld its full-year guidance, citing the uncertainties caused by the Covid-19 outbreak. Following the announcement, the stock gained sharply in early trading on Thursday.
Net income dropped 57% annually to $31.8 million or $0.70 per share and came in below analysts’ estimates. At $206.7 million, revenue was unchanged year-over-year.
In the US, revenues of Impella dropped 3%, while revenues of the flagship product rose 12% in the international market. Abiomed’s stock dropped 31% in the past twelve months. After slipping to a multi-year low last month, the stock is regaining strength.
Most Popular
Key highlights from Deere & Co.’s (DE) Q4 2024 earnings results
Deere & Company (NYSE: DE) reported its fourth quarter 2024 earnings results today. Worldwide net sales and revenues decreased 28% year-over-year to $11.14 billion. Net income was $1.24 billion, or
NVDA Earnings: Nvidia Q3 profit jumps, beats estimates
NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a sharp increase in adjusted profit and revenue for the third quarter of 2025. Earnings also topped analysts' estimates. The tech firm’s revenues
Lowe’s Companies (LOW): A few points to note about the Q3 2024 performance
Shares of Lowe’s Companies, Inc. (NYSE: LOW) rose over 1% on Wednesday. The stock has gained 8% over the past three months. The company delivered better-than-expected earnings results for the